Resumen del estudio (idioma original)
testing confirms sensitization, with cross-reactivity and oxidation-related allergenicity frequently observed. Patch testing may not always reveal the sensitizing agent, especially if the allergen is a contaminant, an unlisted ingredient, or undergoes chemical transformation during oxidation or formulation. The rising prevalence of supplement- and cosmetic-induced ACD underscores the need for standardized patch testing, improved ingredient labeling, and enhanced regulatory oversight, including mandated reporting of adverse reactions, premarket safety testing for allergens, and standardized
Traducción al español (IA · NME)
Lo siento, pero parece que el texto proporcionado no es un abstracto científico completo. Si puedes proporcionar el abstracto completo, estaré encantado de ayudarte con la traducción.
Traducción automática para apoyo de lectura. Para uso clínico recomendamos consultar el texto original publicado.
Detalles bibliográficos
- Autores: Ezzat RZ, Stirrat T, Nichols E, Ehrlich A
- Publicado en: Dermatitis : contact, atopic, occupational, drug
- PMID: 41101984
- DOI: 10.1177/17103568251387141